Company Description
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.
The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery.
Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers.
The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001.
Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
| Country | Switzerland |
| Founded | 1945 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 25,315 |
| CEO | David Endicott |
Contact Details
Address: Chemin de Blandonnet 8, Vernier Geneva, 1214 Switzerland | |
| Phone | 41 589 112 110 |
| Website | alcon.com |
Stock Details
| Ticker Symbol | ALC |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001167379 |
| CUSIP Number | H01301128 |
| ISIN Number | CH0432492467 |
| Employer ID | 98-0205094 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| David J. Endicott | Chief Executive Officer and Director |
| F. Michael Ball | Executive Chairman |
| Arthur B. Cummings M.D. | Executive Director |
| Timothy C. Stonesifer | Chief Financial Officer |
| Ian Bell | Senior Vice President and Chief Operating Officer |
| Margaret Buckley | Chief Accounting Officer |
| Dr. Franck Leveiller | Senior Vice President, Head of Global Research & Development and Chief Scientific Officer |
| Kimberly Martin | Senior Vice President, Chief Human Resources Officer and Corporate Communications |
| Laurent Attias | Head of Corporate Development, Strategy, BD&L and M&A |
| Leon Sergio Duplan Fraustro | President of North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | 6-K | Report of foreign issuer |
| Sep 12, 2024 | 144 | Filing |
| Sep 12, 2024 | 144 | Filing |
| Sep 9, 2024 | 144 | Filing |
| Aug 22, 2024 | 144 | Filing |
| Aug 20, 2024 | 6-K | Report of foreign issuer |
| Jun 24, 2024 | 6-K | Report of foreign issuer |
| Jun 4, 2024 | 144 | Filing |
| Jun 4, 2024 | 144 | Filing |
| May 29, 2024 | SD | Form - SD |